The role of the microbiology laboratory in antimicrobial susceptibility testing

Infections in Medicine

Volumn 16, Issue 8, 1999, Pages 531-532

  Washington, John A ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Clinical Pathology ^*  (United States)

Author keywords

Antimicrobial susceptibility; Diagnostic testing

Indexed keywords

CEPHALOSPORIN DERIVATIVE; GENTAMICIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; DIAGNOSTIC VALUE; LABORATORY TEST; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STANDARDIZATION; TREATMENT PLANNING;

EID: 0032883618     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (2)

1. Rex JA, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis. 1997; 24:235-247.
2. Baquero F. European standards for antimicrobial susceptibility testing: towards theoretical consensus. Eur J Clin Microbiol. 1990;9:492-495.